The MarketWatch News Department was not involved in the creation of this content.-- Phase 1 data for DMX-1001 (noribogaine) support advancement into Phase 2 clinical trial in AUD ...
A new study supported by the National Institutes of Health shows that individuals with alcohol use disorder (AUD) are less likely to receive antivirals for hepatitis C, despite current guidelines ...
A new study supported by the National Institutes of Health shows that individuals with alcohol use disorder (AUD) are less likely to receive antivirals for hepatitis C, despite current guidelines ...
– Respondents Cited the Influence of Their Healthcare Providers and the Positive Impact of Treatment on Their Lives – DUBLIN, April 30, 2025 /PRNewswire/ -- A new online survey conducted by The Harris ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback